Preferred Label : hepatitis C, chronic;

MeSH definition : INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.;

MeSH synonym : chronic hepatitis c;

Details


Main resources

You can consult :

INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

https://www.cochrane.org/fr/CD011929/LIVER_quelle-est-la-precision-du-score-fib-4-et-de-lindice-de-forns-tests-non-invasifs-pour-diagnostiquer
2024
United Kingdom
review of literature
french abstract
cicatrix
hepatitis C, chronic
cues
non-invasive
viral hepatitis c
diagnostic tests
disease
adult
adulthood
fibrosis, liver
healing scar
diagnostic tests, routine
cicatrization
liver
hepatic fibrosis, nos
liver cirrhosis
chronic hepatitis, nos

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatite-c/documents/article/frequence-des-hepatites-chroniques-b-et-c-morbidite-et-mortalite-parmi-la-population-hospitalisee-en-france-2005-2020
2022
France
journal article
Epidemiology
France
french
population
hospital admission, nos
morbidity
France
hepatitis C, chronic
hepatitis B, chronic
Hepatitis
mortality
Epidemiology
Epidemiology
Epidemiology
epidemiology
france
chronic hepatitis, nos
type b viral hepatitis
viral hepatitis c
newsletters
France
periodicals as topic
hospitalization
France
Epidemiologists
Epidemiology

---
http://publications.msss.gouv.qc.ca/msss/document-002023/
http://publications.msss.gouv.qc.ca/msss/document-002024/
http://publications.msss.gouv.qc.ca/msss/document-002025/
2022
false
false
false
Canada
French
practice guideline
patient care management
hepatitis C
quebec
hepatitis C
hepatitis C
antiviral agents
continuity of patient care
antiviral agents
drug interactions
acute disease
drug monitoring
hepatitis C, chronic
hepatitis C antibodies
hepatitis C
serologic tests
fibrosis, liver
predictive value of tests
elbasvir-grazoprevir drug combination
glecaprevir
pibrentasvir
ledipasvir, sofosbuvir drug combination
drug combinations
sofosbuvir-velpatasvir drug combination
voxilaprevir
liver cirrhosis
glecaprevir
quinoxalines
sulfonamides
benzofurans
drug combinations
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
macrocyclic compounds

---
http://beh.santepubliquefrance.fr/beh/2020/31-32/2020_31-32_3.html
2020
France
journal article
resulting in
guideline
Prospectives
hepatitis C, chronic
Antiviral agents
Antiviral drugs
chronic hepatitis, nos
viral hepatitis c
antiviral agents
Hepatitis
guideline

---
https://www.has-sante.fr/jcms/c_2886668/fr/evaluation-des-strategies-de-depistage-des-personnes-infectees-par-le-virus-de-l-hepatite-c-vhc-volet-1-evaluer-l-efficience-des-strategies-de-depistage
2019
false
false
false
France
hepatitis C
economic evaluation
efficiency
hepatitis C
france
public health guidelines
hepatitis C
population at risk
incidence
prevalence
risk factors
coinfection
hiv infections
hepatitis C
hepatitis C antibodies
hepatitis C, chronic
hepacivirus
mass screening

---
http://beh.santepubliquefrance.fr/beh/2019/24-25/2019_24-25_5.html
2019
false
false
false
France
france
hepatitis C, chronic
journal article
antiviral agents
patient care management
hepatitis C, chronic
insurance, health, reimbursement

---
http://beh.santepubliquefrance.fr/beh/2019/24-25/2019_24-25_1.html
2019
false
false
false
France
adult
journal article
mass screening
hepatitis C, chronic
prevalence
hepatitis B, chronic
france

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2019-antiviraux-action-directe-traitement-hepatite-c
2019
France
journal article
hepatitis C, chronic
Antiviral agents
viral hepatitis c
Hepatitis
guideline
chronic hepatitis, nos
Antiviral drugs
antiviral agents
leadership

---
http://www.theses.fr/2019SACLS473
2019
France
dissertations, academic
France
Hepatitis
France
chronic hepatitis, nos
France
france
viral hepatitis
viral hepatitis c
french
France
patient care management
hepatitis C, chronic

---
https://afef.asso.fr/wp-content/uploads/2018/06/RecommandationsAFEFMars2017.pdf
2017
false
false
true
France
French
hepatitis C, chronic
practice guideline
severity of illness index
drug administration schedule
genotype
antiviral agents
drug resistance, viral
liver cirrhosis
liver transplantation
renal insufficiency
drug users
prisoners
watchful waiting
hepatitis C, chronic

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Product containing ombitasvir and paritaprevir and ritonavir in oral dose form (medicinal product form)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
dasabuvir
ombitasvir
paritaprevir
daclatasvir
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
http://www.has-sante.fr/portail/jcms/c_2728866/fr/reevaluation-des-antiviraux-d-action-directe-dans-le-traitement-de-l-hepatite-c
2016
false
false
false
France
French
guidelines for drug use
practice guideline
antiviral agents
hepatitis C, chronic
drug evaluation
Sofosbuvir
administration, oral
Simeprevir
direct acting antivirals
daclatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
drug therapy, combination
ritonavir
ombitasvir
paritaprevir
dasabuvir
drug resistance, viral
drug interactions
treatment outcome
daclatasvir
ombitasvir
paritaprevir
dasabuvir
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
anilides
carbamates
macrocyclic compounds
sulfonamides
uracil
uracil

---
http://www.has-sante.fr/portail/jcms/c_2633680/fr/antiviraux-d-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
adult
hepatitis C, chronic
drug therapy, combination
Sofosbuvir
antiviral agents
direct acting antivirals
daclatasvir
Simeprevir
ledipasvir, sofosbuvir drug combination
dasabuvir
drug combinations
ombitasvir
ritonavir
paritaprevir
fibrosis, liver
risk
has patient
hepacivirus
Infections
autoimmune diseases
hepatic fibrosis, nos
fibrosis
hepatitis C virus
human enterovirus 72
hepatitis C, chronic
business
liver cirrhosis
socialism
patients
chronic infectious disease
guideline
antiviral agents
chronic hepatitis, nos
health
case management
hepatitis c virus
hepatitis a virus
dasabuvir
ombitasvir
paritaprevir
daclatasvir
fibrosis
commerce
patients
guideline
benzimidazoles
fluorenes
uridine monophosphate
sulfonamides
uracil
uracil
anilides
carbamates
macrocyclic compounds
imidazoles

---
Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/61274a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
hepatitis C, chronic
adult
direct acting antivirals
antiviral agents
Hepatitis B reactivation
hepatitis B
risk assessment
product surveillance, postmarketing
canada
patient education handout
risk
daclatasvir
Sofosbuvir
Simeprevir
velpatasvir
ledipasvir
ledipasvir, sofosbuvir drug combination
dasabuvir
ritonavir
sofosbuvir-velpatasvir drug combination
daclatasvir
dasabuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
imidazoles
sulfonamides
uracil
uracil
drug combinations

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=41286
2016
false
false
false
France
French
legislation
guideline
hepatitis C, chronic
antiviral agents
drug prescriptions
interdisciplinary medical team conference, nos
continuity of patient care

---
http://www.amub-ulb.be/revue-medicale-bruxelles/article/prise-en-charge-de-lhepatite-c-chronique-en-2016-1210
2016
false
true
false
Belgium
French
journal article
hepatitis C, chronic
hepatitis C, chronic
hepatitis C, chronic
general practice
general practitioners
hepatitis C, chronic

---
https://afef.asso.fr/wp-content/uploads/2018/06/VF-INTERACTIF-RECO-VHC-AFEF-v2103.pdf
http://www.infectiologie.com/UserFiles/File/medias/Recos/2015-juin-Recommandations-AFEF-Hepatite-C.pdf
2016
false
false
true
false
France
French
hepatitis C, chronic
practice guideline
severity of illness index
hepatitis C, chronic
antiviral agents
comorbidity
genotype
daclatasvir
ledipasvir
ribavirin
treatment outcome
drug resistance, viral
pregnancy
patient education as topic
liver cirrhosis
liver transplantation
recurrence
renal insufficiency
child
adolescent
drug users
hiv infections
acute disease
Acute hepatitis C
Simeprevir
Sofosbuvir
ledipasvir
ledipasvir, sofosbuvir drug combination
daclatasvir
imidazoles
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate

---
https://sante.gouv.fr//IMG/pdf/Lettre_d_instruction_prise_en_charge_hepatite_C_30_avril_2015.pdf
2015
false
false
false
France
French
guideline
hepatitis C, chronic
antiviral agents
drug therapy, combination
interdisciplinary medical team conference, nos
antiviral agents
adult
drug prescriptions
pharmacy service, hospital
continuity of patient care
patient care management
daclatasvir
ledipasvir
professional role
health occupations
Simeprevir
Sofosbuvir
daclatasvir
imidazoles

---
http://www.revmed.ch/RMS/2015/RMS-N-471/Hepatite-C-traitement-actuel
2015
false
false
false
Switzerland
French
journal article
hepatitis C, chronic
antiviral agents

---
http://www.revmed.ch/RMS/2015/RMS-N-471/Hepatite-C-epidemiologie-histoire-naturelle-et-diagnostic
2015
false
false
false
Switzerland
French
journal article
hepatitis C, chronic
hepatitis C, chronic
hepacivirus
hepatitis C, chronic
hepatitis C, chronic

---
https://dumas.ccsd.cnrs.fr/dumas-01379413
2015
false
false
false
France
French
dissertations, academic
hepatitis C, chronic
viral hepatitis
treaties
therapeutics
viral hepatitis c
adult
chronic hepatitis, nos
adulthood
international cooperation

---
https://www.inserm.fr/information-en-sante/dossiers-information/hepatite
2014
false
false
false
France
French
hepatitis C, chronic
scientific and technical information

---
https://sante.gouv.fr//IMG/pdf/experts-vih_actualisations2014.pdf
https://medias.vie-publique.fr/data_storage_s3/rapport/pdf/144000578.pdf
2014
false
false
false
France
French
hiv infections
anti-hiv agents
adult
practice guideline
anti-hiv agents
coinfection
hepatitis C, chronic
drug interactions
hepatitis C, chronic
antiviral agents
antiviral agents
hepatitis C
acute disease
algorithms
hepatitis B, chronic

---
http://www.cochrane.org/fr/CD011132/les-aminoadamantanes-par-rapport-a-dautres-medicaments-antiviraux-pour-le-traitement-de-lhepatite-c-chronique
2014
false
false
false
France
United Kingdom
French
meta-analysis
french abstract
hepatitis C, chronic
antiviral agents
amantadine
treatment outcome

---
https://www.inspq.qc.ca/publications/1872
https://www.inspq.qc.ca/sites/default/files/publications/1872_evaluation_suivi_soignants_vhc.pdf
2014
false
false
false
Canada
French
hepatitis C
health personnel
practice guideline
infectious disease transmission, Professional-to-Patient
hepatitis C, chronic
algorithms
students, medical

---
https://phc.swisshealthweb.ch/fr/article/doi/phc-f.2014.00764/
2014
false
false
false
Switzerland
French
journal article
opiate substitution treatment
general practice
general practitioners
hepatitis C, chronic

---
http://www.cochrane.org/fr/CD010125/les-aminoadamantanes-pour-lhepatite-c-chronique
2014
false
false
false
France
United Kingdom
French
meta-analysis
french abstract
hepatitis C, chronic
amantadine
treatment outcome
antiviral agents

---
http://www.cochrane.org/fr/CD005642/peg-interferon-alpha-2a-versus-peg-interferon-alpha-2b-pour-lhepatite-c-chronique
2014
false
false
false
France
United Kingdom
meta-analysis
french abstract
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
treatment outcome
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
polyethylene glycols
recombinant proteins
polyethylene glycols
recombinant proteins

---
http://www.cochrane.org/fr/CD005441/lassociation-de-peg-interferon-et-de-ribavirine-est-plus-efficace-que-linterferon-associe-au-ribavirine-pour-eliminer-le-virus-de-lhepatite-c
2014
false
false
false
France
United Kingdom
meta-analysis
french abstract
drug therapy, combination
interferons
ribavirin
hepatitis C, chronic
treatment outcome
antiviral agents
interferons
antiviral agents
hepatitis C, chronic
ribavirin

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/hepatites-virales/hepatites-b-et-d/documents/article/prevalence-morbidite-et-mortalite-associees-aux-hepatites-b-et-c-chroniques-dans-la-population-hospitalisee-en-france-2004-2011
2014
false
false
false
France
journal article
hepatitis C, chronic
hepatitis C, chronic
hepatitis B, chronic
cross infection
hepatitis B, chronic
hepatitis B, chronic
hepatitis B, chronic
comorbidity
france

---
http://www.rfi.fr/emission/20141017-journee-nationale-depistage-hepatite-pawlotsky-elouardighi/
2014
false
false
false
France
French
radio broadcast
hepatitis C, chronic
hepatitis C, chronic

---
http://www.cochrane.org/fr/CD003617
2013
United Kingdom
France
French
french abstract
meta-analysis
hepatitis C, chronic
interferons
recurrence
treatment outcome
antiviral agents

---
http://www.reseauhepatites5962.com/
France
French
hepatitis B, chronic
hepatitis C, chronic
community networks

---
https://www.amub-ulb.be/system/files/rmb/old/828
2012
Belgium
French
hepatitis C, chronic
journal article

---
http://www.cochrane.org/fr/CD008516
2012
false
true
false
United Kingdom
France
time
treatment outcome
polyethylene glycols
Sustained Virologic Response
review of literature
french abstract
hepatitis C, chronic
adult
ribavirin

---
http://www.cochrane.org/fr/CD004888
2010
United Kingdom
France
French
french abstract
meta-analysis
treatment outcome
hiv infections
hepatitis C, chronic
antiviral agents

---
http://www.cochrane.org/fr/CD005445
2010
United Kingdom
France
French
french abstract
meta-analysis
hepatitis C, chronic
interferons
treatment outcome
ribavirin
drug therapy, combination
antiviral agents
comparative study

---
http://www.cochrane.org/fr/CD006573
2010
United Kingdom
France
French
secondary prevention
french abstract
meta-analysis
chemoprevention
antiviral agents
hepatitis C, chronic
liver transplantation
treatment outcome

---
https://www.revmed.ch/RMS/2010/RMS-233/Le-point-sur-le-traitement-de-l-hepatite-C-chronique
2010
Switzerland
French
journal article
hepatitis C, chronic
antiviral agents

---
http://www.has-sante.fr/portail/jcms/c_945526/neorecormon-dans-le-traitement-de-l-anemie-du-patient-traite-pour-une-infection-du-virus-de-l-hepatite-c
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-05/neorecormonhepatitec_art_56_avishas.pdf
2010
France
French
erythropoietin
recombinant proteins
epoetin beta
anemia
erythropoietin
hepatitis C, chronic
adult
ribavirin
injections
anemia
antiviral agents
drug information

---
http://www.has-sante.fr/portail/jcms/c_841617/viraferon-peg-peginterferon-alfa-interferon
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-01/viraferon_peg_-_ct-5474.pdf
2008
France
French
peginterferon alfa-2b
hepatitis C, chronic
antiviral agents
peginterferon alfa-2b
polyethylene glycols
polyethylene glycols
evaluation of the transparency committee
guidelines for drug use

---
https://www.revmed.ch/RMS/2008/RMS-169/Hepatite-C-et-resistance-a-l-insuline
2008
Switzerland
French
hepatitis C, chronic
insulin resistance
diabetes mellitus, type 2
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_480817
2007
France
French
hepatitis C, chronic
continuity of patient care
patient care management
patients guideline

---
http://www.has-sante.fr/portail/display.jsp?id=c_434397
2007
true
France
French
hepatitis C, chronic
continuity of patient care
continuity of patient care
patient care
professional role
hepatitis C, chronic
patient education as topic
health behavior
professional practice
patient care management
practice guideline
patient education handout

---
https://drees.solidarites-sante.gouv.fr/sites/default/files/2020-10/er470.pdf
2006
France
French
hepatitis C, chronic
hepatitis C, chronic
general practitioners
general practice
hospitalization
ambulatory care
hepatitis C, chronic
hepatitis C, chronic
france
hiv infections
coinfection
patient care management
journal article
table

---
http://www.has-sante.fr/portail/jcms/c_750188/ald-n6-hepatite-chronique-c
2006
false
France
French
hepatitis C, chronic
patient education handout

---
https://www.amub-ulb.be/system/files/rmb/old/213
2005
Belgium
French
mass screening
hepatitis C, chronic
pregnancy
journal article

---
https://drees.solidarites-sante.gouv.fr/sites/default/files/er368.pdf
2005
France
French
journal article
table
graph
hepatitis C, chronic
hepatitis C, chronic
risk factors
france
health surveys
age distribution
sex distribution
patient care
hepatitis C, chronic
continuity of patient care
hepatitis C, chronic
hepatitis C, chronic
patient satisfaction
information dissemination
hepatitis C, chronic
social support
quality of life
patient care

---
http://revmed.ch/RMS/2005/RMS-3/30078
2005
Switzerland
French
hepatitis B, chronic
hepatitis C, chronic
journal article

---
https://www.cadth.ca/sites/default/files/pdf/171_hepc_tr_f.pdf
https://www.cadth.ca/fr/ievaluation-des-resultats-cliniques-des-traitements-par-linterferon-de-lhepatite-chronique-c
2004
true
Canada
French
treatment outcome
interferons
hepatitis C, chronic
ribavirin
antiviral agents
bibliography of medicine
interferon-alpha
randomized controlled trials as topic
mortality
quality of life
drug therapy, combination
interferons
antiviral agents
ribavirin
morbidity
interferons
antiviral agents
ribavirin
interferons
evaluation studies
table
technical report
drug evaluation

---
https://www.santepubliquefrance.fr/recherche/#search=Numéro+thématique+consacré+à+l'épidémiologie+de+l'hépatite+C
2003
France
French
france
hepatitis C
sentinel surveillance
hepatitis C
hepatitis C
mass screening
mass screening
sensitivity and specificity
laboratories
sex
community networks
data collection
risk factors
hepatitis C, chronic
hepatitis C
hepatitis C
substance-related disorders
hepatitis C
age distribution
prevalence
hiv infections
acquired immunodeficiency syndrome
cross infection
hemodialysis units, hospital
renal dialysis
journal article

---
http://www.has-sante.fr/portail/display.jsp?id=c_271876
2002
France
French
guidelines
ribavirin
adult
child
france
hepatitis C
incidence
hepatitis C, chronic
liver cirrhosis
recurrence
ribavirin
alcohol drinking
substance-related disorders
hiv infections
acquired immunodeficiency syndrome
aged
transaminases
hepatitis C
biopsy, needle
biopsy, needle
hepatitis C
antiviral agents
ribavirin
interferons
interferons
antiviral agents
antiviral agents
smoking
continuity of patient care
treatment outcome
antiviral agents
quality of life
hepatitis C
Contraindications, Procedure
Contraindications, Drug
severity of illness index
interferons
liver transplantation
mental disorders
medical history taking
hepatitis C
drug therapy, combination
interferons
ribavirin
communication
coinfection
consensus

---
https://www.santepubliquefrance.fr/recherche/#search=Nouveaux+cycles+de+traitement+pour+hépatite+C+chronique+dans+les+établissements+de+santé+(Les)
2000
France
French
hepatitis C, chronic
hospitals
guideline adherence
journal article

---
https://www.santepubliquefrance.fr/recherche/#search=Enquête+sur+les+patients+mis+sous+traitement+pour+hépatite+C+chronique+dans+les+établissements+de+santé
1999
France
French
journal article
hepatitis C, chronic
health surveys

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.